Digital Aria Co Ltd (115450) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.015x

Based on the latest financial reports, Digital Aria Co Ltd (115450) has a cash flow conversion efficiency ratio of -0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.66 Billion ≈ $-1.80 Million USD) by net assets (₩176.02 Billion ≈ $119.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 115450 market cap for the company's overall valuation and market capitalisation.

Digital Aria Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Digital Aria Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Digital Aria Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Digital Aria Co Ltd ranked by their cash flow conversion efficiency. Explore Digital Aria Co Ltd (115450) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Méliuz S.A
SA:CASH3
0.012x
Yeong Hwa Meta
KO:012280
0.097x
Cornish Metals Inc.
V:CUSN
-0.014x
Dwi Guna Laksana Tbk PT
JK:DWGL
-0.045x
John Hancock Income Securities Closed Fund
NYSE:JHS
0.026x
Mnc Investama Tbk
JK:BHIT
0.006x
NOVAREX Co.Ltd
KQ:194700
0.041x
SAI SILKS (KALAMANDIR) LIMITED
NSE:KALAMANDIR
0.143x

Annual Cash Flow Conversion Efficiency for Digital Aria Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Digital Aria Co Ltd from 2011 to 2025. View Digital Aria Co Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩173.86 Billion
≈ $117.82 Million
₩-8.18 Billion
≈ $-5.54 Million
-0.047x -675.17%
2024-12-31 ₩157.46 Billion
≈ $106.71 Million
₩1.29 Billion
≈ $872.70K
0.008x -57.84%
2023-12-31 ₩171.52 Billion
≈ $116.24 Million
₩3.33 Billion
≈ $2.25 Million
0.019x +125.70%
2022-12-31 ₩116.71 Billion
≈ $79.09 Million
₩-8.81 Billion
≈ $-5.97 Million
-0.075x +20.51%
2021-12-31 ₩118.68 Billion
≈ $80.43 Million
₩-11.27 Billion
≈ $-7.64 Million
-0.095x +27.18%
2020-12-31 ₩89.35 Billion
≈ $60.55 Million
₩-11.65 Billion
≈ $-7.90 Million
-0.130x -50.39%
2019-12-31 ₩63.94 Billion
≈ $43.33 Million
₩-5.54 Billion
≈ $-3.76 Million
-0.087x -68.84%
2018-12-31 ₩68.66 Billion
≈ $46.53 Million
₩-3.53 Billion
≈ $-2.39 Million
-0.051x +57.63%
2017-12-31 ₩38.44 Billion
≈ $26.05 Million
₩-4.66 Billion
≈ $-3.16 Million
-0.121x -51.17%
2016-12-31 ₩33.88 Billion
≈ $22.96 Million
₩-2.72 Billion
≈ $-1.84 Million
-0.080x +43.87%
2015-12-31 ₩30.08 Billion
≈ $20.39 Million
₩-4.30 Billion
≈ $-2.91 Million
-0.143x +39.24%
2014-12-31 ₩22.52 Billion
≈ $15.26 Million
₩-5.29 Billion
≈ $-3.59 Million
-0.235x -327.84%
2011-12-31 ₩18.38 Billion
≈ $12.46 Million
₩1.90 Billion
≈ $1.29 Million
0.103x --

About Digital Aria Co Ltd

KQ:115450 Korea Biotechnology
Market Cap
$122.47 Million
₩180.72 Billion KRW
Market Cap Rank
#18519 Global
#843 in Korea
Share Price
₩2050.00
Change (1 day)
+0.74%
52-Week Range
₩1451.00 - ₩3980.00
All Time High
₩25764.90
About

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrica… Read more